Physician profile
Sanjog Kalra
NPI 1124409826
$443,798.83
in general payments reported to CMS, 2019-2025
22 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,568 · 2020: $2,582 · 2021: $83K · 2022: $137K · 2023: $83K · 2024: $129K · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $119K · Honoraria: $89K · Travel and Lodging: $2,211 · Food and Beverage: $1,204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $119,449.28 |
| Honoraria | $88,900.00 |
| Travel and Lodging | $2,211.14 |
| Food and Beverage | $1,204.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $224,201.88 | 2019-2024 | Opticross, Avvigo Guidance System, Rotawire and Wireclip Torquer |
| Abiomed | $196,864.33 | 2019-2025 | Impella |
| Cardiovascular Systems INC. | $11,339.77 | 2019-2022 | |
| Biotronik INC. | $4,435.62 | 2020-2022 | |
| Abbott Laboratories | $2,648.89 | 2019-2023 | Diamondback Coronary |
| Livanova USA, INC. | $926.51 | 2019 | |
| Avinger INC. | $835.67 | 2019-2023 | Pantheris |
| Shockwave Medical, INC | $533.27 | 2019-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Asahi Intecc USA, INC. | $360.03 | 2019-2020 | |
| Philips North America LLC | $345.17 | 2019-2020 | |
| Medtronic, INC. | $278.95 | 2021-2023 | Onyx Frontier |
| Medtronic Vascular, INC. | $243.35 | 2019-2020 | |
| Celonova Biosciences, INC. | $181.40 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $145.78 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $130.04 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $78.25 | 2019-2020 | |
| Chiesi USA, INC. | $77.05 | 2019 | |
| Terumo Medical Corporation | $66.84 | 2019-2020 | |
| Cardiva Medical, INC. | $43.94 | 2019 | |
| Amgen INC. | $30.60 | 2019-2020 | |
| Corindus INC. | $17.18 | 2019 | |
| Teleflex LLC | $14.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjog Kalra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.